Healthcare
Pascal Orliac

WHY BROKERS, ADVISERS AND BENEFITS PROFESSIONALS SHOULD CONSIDER CARE2CARE’S OFFER ON PRESCRIPTION DRUGS

WHY BROKERS, ADVISERS AND BENEFITS PROFESSIONALS SHOULD CONSIDER CARE2CARE’S OFFER ON PRESCRIPTION DRUGS André Wencker CEO of Care2Care Medical Travel March 2019 In August 2018, a team of researchers produced a study on the annual and per-member-per-month (PMPM) spending on prescription medications for Harvard Pilgrim Health Care (HPHC), compared to the total

Read More »
Healthcare
Pascal Orliac

The high cost of prescription drugs in the USA

HIGH-COST PRESCRIPTION DRUGS: PRICE COMPARISON USA – FRANCE REFLECTING ON THE HOW AND WHY By André Wencker CEO, Care2Care In august this year, a team of researchers produced a study on the annual and per-member-per-month (PMPM) spending on prescription medications for Harvard Pilgrim Health Care (HPHC), compared to the total

Read More »
Healthcare
Pascal Orliac

IT’S SURGERY, STUPID!

IT’S SURGERY, STUPID! By ANDRE WENCKER CEO, Care2Care I. AHIP’S CONFUSING DOCUMENT ON HEALTHCARE COSTS American Health Insurance Plans-AHIP, is the well-known national trade association of health plans and Insurers; hence its views on healthcare spending in Employer Sponsored Insurance (ESI) are expected to be precise and extensive. This is

Read More »
France tourism
Pascal Orliac

MEDICAL TOURISM: WHY FRANCE SHOULD BECOME A PRIORITY DESTINATION

MEDICAL TOURISM: WHY FRANCE COULD BECOME A PRIORITY DESTINATION Medical tourism represents a significant market worldwide: roughly 6O billion €  according to recent estimates Over 6 million patients sought medical care abroad in 2007; 16 million in 2013.. By VICTOR RODWIN France is the top destination In some countries, health

Read More »